Skip to main content
Clinical Trials/NCT01079754
NCT01079754
Unknown
Phase 4

The Comparison of 0.05 vs. 0.1 Milligram Spinal Morphine for Reducing Morphine Requirement After Vaginal Hysterectomy With/Without Anterior and Posterior Vaginoplasty

Mahidol University1 site in 1 country72 target enrollmentMarch 2010

Overview

Phase
Phase 4
Intervention
Spinal morphine 0.05 mg
Conditions
Pain
Sponsor
Mahidol University
Enrollment
72
Locations
1
Primary Endpoint
The total amount of morphine that the patient required during the first 24-h postoperative.
Last Updated
14 years ago

Overview

Brief Summary

This study aims to compare the efficacy of 0.05 mg and 0.1 mg spinal morphine in reducing postoperative morphine requirement in patients undergoing vaginal hysterectomy with/without anterior and posterior vaginoplasty.

Registry
clinicaltrials.gov
Start Date
March 2010
End Date
December 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sirilak Suksompong

Associate Professor

Mahidol University

Eligibility Criteria

Inclusion Criteria

  • Female ASA physical status 1-3
  • Undergoing vaginal hysterectomy with/without anterior and posterior vaginoplasty
  • Be able to operate patient-controlled analgesia (PCA)

Exclusion Criteria

  • Allergy to the study drugs
  • History of bleeding tendency
  • Infection at the back
  • Refuse to spinal anesthesia
  • History of CAD or CVA

Arms & Interventions

Spinal morphine 0.05 mg

Patient received spinal morphine 0.05 mg

Intervention: Spinal morphine 0.05 mg

Spinal morphine 0.1 mg

Patient received spinal morphine 0.1 mg

Intervention: Spinal morphine 0.1 mg

Outcomes

Primary Outcomes

The total amount of morphine that the patient required during the first 24-h postoperative.

Time Frame: 24 hours

Study Sites (1)

Loading locations...

Similar Trials